Compile Data Set for Download or QSAR
Report error Found 24 Enz. Inhib. hit(s) with all data for entry = 12302
TargetTGF-beta receptor type-1(Human)
Clavius Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 694365BDBM694365(US12077548, Compound 96)
Affinity DataIC50: 1.70nMAssay Description:Exemplified compounds are screened in 1% DMSO (final concentration) by 3-fold serial dilutions from 10,000 nM to 0.316 nM or at single concentrations...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Clavius Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 694349BDBM694349(US12077548, Compound 24)
Affinity DataIC50: 1.80nMAssay Description:Exemplified compounds are screened in 1% DMSO (final concentration) by 3-fold serial dilutions from 10,000 nM to 0.316 nM or at single concentrations...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Clavius Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 694359BDBM694359(US12077548, Compound 90)
Affinity DataIC50: 2.5nMAssay Description:Exemplified compounds are screened in 1% DMSO (final concentration) by 3-fold serial dilutions from 10,000 nM to 0.316 nM or at single concentrations...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Clavius Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 694358BDBM694358(US12077548, Compound 89)
Affinity DataIC50: 2.5nMAssay Description:Exemplified compounds are screened in 1% DMSO (final concentration) by 3-fold serial dilutions from 10,000 nM to 0.316 nM or at single concentrations...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Clavius Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 694345BDBM694345(US12077548, Compound 16)
Affinity DataIC50: 2.60nMAssay Description:Exemplified compounds are screened in 1% DMSO (final concentration) by 3-fold serial dilutions from 10,000 nM to 0.316 nM or at single concentrations...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Clavius Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 694351BDBM694351(US12077548, Compound 26)
Affinity DataIC50: 3.10nMAssay Description:Exemplified compounds are screened in 1% DMSO (final concentration) by 3-fold serial dilutions from 10,000 nM to 0.316 nM or at single concentrations...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Clavius Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 694344BDBM694344(US12077548, Compound 8)
Affinity DataIC50: 3.30nMAssay Description:Exemplified compounds are screened in 1% DMSO (final concentration) by 3-fold serial dilutions from 10,000 nM to 0.316 nM or at single concentrations...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Clavius Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 694348BDBM694348(US12077548, Compound 23)
Affinity DataIC50: 5.20nMAssay Description:Exemplified compounds are screened in 1% DMSO (final concentration) by 3-fold serial dilutions from 10,000 nM to 0.316 nM or at single concentrations...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Clavius Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 694343BDBM694343(US12077548, Compound 7)
Affinity DataIC50: 5.5nMAssay Description:Exemplified compounds are screened in 1% DMSO (final concentration) by 3-fold serial dilutions from 10,000 nM to 0.316 nM or at single concentrations...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Clavius Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 694346BDBM694346(US12077548, Compound 18)
Affinity DataIC50: 6.70nMAssay Description:Exemplified compounds are screened in 1% DMSO (final concentration) by 3-fold serial dilutions from 10,000 nM to 0.316 nM or at single concentrations...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Clavius Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 694350BDBM694350(US12077548, Compound 25)
Affinity DataIC50: 7.20nMAssay Description:Exemplified compounds are screened in 1% DMSO (final concentration) by 3-fold serial dilutions from 10,000 nM to 0.316 nM or at single concentrations...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Clavius Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 694347BDBM694347(US12077548, Compound 22)
Affinity DataIC50: 7.20nMAssay Description:Exemplified compounds are screened in 1% DMSO (final concentration) by 3-fold serial dilutions from 10,000 nM to 0.316 nM or at single concentrations...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Clavius Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 694364BDBM694364(US12077548, Compound 95)
Affinity DataIC50: 8.90nMAssay Description:Exemplified compounds are screened in 1% DMSO (final concentration) by 3-fold serial dilutions from 10,000 nM to 0.316 nM or at single concentrations...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Clavius Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 694361BDBM694361(US12077548, Compound 92)
Affinity DataIC50: 11nMAssay Description:Exemplified compounds are screened in 1% DMSO (final concentration) by 3-fold serial dilutions from 10,000 nM to 0.316 nM or at single concentrations...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Clavius Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 694366BDBM694366(US12077548, Compound 97)
Affinity DataIC50: 12.5nMAssay Description:Exemplified compounds are screened in 1% DMSO (final concentration) by 3-fold serial dilutions from 10,000 nM to 0.316 nM or at single concentrations...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Clavius Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 694360BDBM694360(US12077548, Compound 91)
Affinity DataIC50: 22nMAssay Description:Exemplified compounds are screened in 1% DMSO (final concentration) by 3-fold serial dilutions from 10,000 nM to 0.316 nM or at single concentrations...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Clavius Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 694363BDBM694363(US12077548, Compound 94)
Affinity DataIC50: 27nMAssay Description:Exemplified compounds are screened in 1% DMSO (final concentration) by 3-fold serial dilutions from 10,000 nM to 0.316 nM or at single concentrations...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Clavius Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 694353BDBM694353(US12077548, Compound 49)
Affinity DataIC50: 52nMAssay Description:Exemplified compounds are screened in 1% DMSO (final concentration) by 3-fold serial dilutions from 10,000 nM to 0.316 nM or at single concentrations...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Clavius Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 694357BDBM694357(US12077548, Compound 88)
Affinity DataIC50: 55nMAssay Description:Exemplified compounds are screened in 1% DMSO (final concentration) by 3-fold serial dilutions from 10,000 nM to 0.316 nM or at single concentrations...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Clavius Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 694355BDBM694355(US12077548, Compound 75)
Affinity DataIC50: 66nMAssay Description:Exemplified compounds are screened in 1% DMSO (final concentration) by 3-fold serial dilutions from 10,000 nM to 0.316 nM or at single concentrations...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Clavius Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 694354BDBM694354(US12077548, Compound 50)
Affinity DataIC50: 90nMAssay Description:Exemplified compounds are screened in 1% DMSO (final concentration) by 3-fold serial dilutions from 10,000 nM to 0.316 nM or at single concentrations...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Clavius Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 694352BDBM694352(US12077548, Compound 28)
Affinity DataIC50: 107nMAssay Description:Exemplified compounds are screened in 1% DMSO (final concentration) by 3-fold serial dilutions from 10,000 nM to 0.316 nM or at single concentrations...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Clavius Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 694356BDBM694356(US12077548, Compound 86)
Affinity DataIC50: 129nMAssay Description:Exemplified compounds are screened in 1% DMSO (final concentration) by 3-fold serial dilutions from 10,000 nM to 0.316 nM or at single concentrations...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent

TargetTGF-beta receptor type-1(Human)
Clavius Pharmaceuticals

US Patent
LigandChemical structure of BindingDB Monomer ID 694362BDBM694362(US12077548, Compound 93)
Affinity DataIC50: 244nMAssay Description:Exemplified compounds are screened in 1% DMSO (final concentration) by 3-fold serial dilutions from 10,000 nM to 0.316 nM or at single concentrations...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/16/2024
Entry Details
US Patent